Stock Price & Analysis

Based on the provided data and recent market analysis, here's a comprehensive evaluation of VEEV stock:

Technical Analysis

The stock is currently showing mixed technical signals:

• Recent close at $221.64 with RSI-14 at 43.60 indicating neutral momentum
• Trading below SMA-20 ($232.84) but above SMA-200 ($208.78)
• MACD line at 1.57 with negative histogram (-1.41) suggests short-term weakness

Fundamental Strength

Key financial metrics show solid fundamentals:

• Strong revenue growth from $2.16B (2023) to projected $2.36B (2024)
• Healthy gross margin of 71.35%
• Zero debt-to-equity ratio indicates strong balance sheet
• Current ratio of 4.24 demonstrates excellent liquidity

Analyst Sentiment

Recent analyst coverage is positive:

• Barclays maintains Buy rating with $275 price target
• Overall consensus is Moderate Buy with average target of $264.04
• Trading well below highest analyst target, suggesting upside potential

Recommendation

SELL for these reasons:

1. Technical indicators show short-term weakness with price below key moving averages
2. RSI trending lower suggests momentum is fading
3. Pre-market trading at $227.27 (+0.66%) provides a good exit opportunity
4. Current price represents fair value given near-term headwinds

Based on recent market data and industry analysis, Veeva Systems (VEEV) stock is projected to reach $275-285 by end of 2025, driven by continued strong growth in life sciences cloud solutions market and improving profit margins. The company's specialized cloud solutions for life sciences companies and high switching costs create a strong competitive moat, while its total addressable market of $20 billion provides significant room for expansion from current $2.7 billion revenue. Recent analyst consensus shows positive momentum with improving earnings estimates, supporting this bullish price target.

The S1 support level for VEEV Stock is $220.5 ,The R1 resistant level for VEEV Stock is $233.92.

As of the end of day on 2025-02-27, the price of VEEV Stock was $220.82.

The target price for VEEV Stock according to analyst rating is 264.04, with the highest price target at 307.00 and the lowest at 195.00. Analysts have a Moderate Buy rating on VEEV Stock overall.

The market cap of VEEV is $35.9B.

Based on the provided data and current valuation metrics, VEEV appears to be reasonably valued with some signs of overvaluation. The stock's current P/E ratio of 59.64 shows a significant improvement from its 2022 level of 78.32, though still higher than the 2023 level of 50.08. The EV/EBITDA ratio at 61.17 indicates premium pricing compared to industry standards. The P/S ratio of 14.35 suggests the market is pricing in strong future growth expectations.

Technical Analysis The stock is currently showing bearish signals with RSI-14 at 43.60 in neutral territory but trending down. The stock is trading between its SMA-20 (232.84) and SMA-60 (226.29), with current price at 227.27 indicating a consolidation phase.

Growth & Market Position Veeva maintains its position as the global leading supplier of cloud-based software solutions for life sciences. Revenue growth remains solid at 10.73% year-over-year, with impressive net margins of 26.57% demonstrating strong operational efficiency.

Analyst Sentiment Recent analyst coverage shows mixed but generally positive sentiment, with 18 out of 26 analysts rating the stock as Bullish or Somewhat Bullish. The average price target of $264.27 represents potential upside from current levels.

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Based on the available data and market analysis, here is the 2030 price prediction for VEEV stock:

VEEV stock is projected to reach $475-500 by 2030, representing a ~120% upside from current levels. This forecast is supported by Veeva's dominant position in life sciences cloud solutions, consistent revenue growth trajectory, and expanding $20 billion total addressable market. The company's high switching costs and specialized solutions for regulated industries provide strong competitive advantages for sustained growth.

VEEV has a total of 7172 employees.